glp-1 agonists vs bariatric surgery weight loss comparison GLP-1RAs offer comparable to with fewer side effects In this cohort study of
Description
For these reasons, limited treatment options exist for this patient population
eClinicalMedicine 58 , 101962 (2023)
Several studies have shown that tirzepatide reduces insulin resistance, improves glycemic control, and lowers inflammatory biomarkers, including C-reactive protein and IL-6 (46, 47)
BMJ , e075354
